To determine the role of glucagon in idiopathic leucine-sensitive hypoglycemia (LSH) and the effects of oral diazoxide (D), responses to oral L-leucine (L) were studied in 3 LSH children and in 6 controls. In controls mean plasma insulin (IRI), glucose (G) and glucagon (IRG) values were unchanbed after L, 150 mglkg. In LSH children after L. 50 mglkg, meanfSEM plasma IRI rose from 14f3 to 41f5 pU/ml, mean plasma G fell from 72f4 to 35f3 mgldl, mean plasma IRG increased 48f8X; each significantly different from baaeline (P<0.025).
Dominantly transmitted asymptomatic HPI was discovered in 4 generations of a family by Gabbay e t a t . We add 2 instances of a white newborn girl and a black 11-month-old boy with profound HG. The girl developed HG (<5mg/dl) at 30 hrs with hypothermia and seizures; she was poorly controlled with cortisol and IV glucose (G), very sensitive to glucagon at 2 wks (from 19 to 70 mgl dl) and rapidly responsive to oral diazoxide (DZX). DZX suppressed insulin (I) levels from max lOOpUlml at 19mgldl G to 7 at 142mgldl. 80% pancreatectomy was done at age 10 wks; nesidioblastosis was found. Remission lasted 2 nos. DZX was again effective; the most recent effort to stop DZX, at age 5, failed after 10 days without drug when G was 17-40mgld1, I ZOvUIml and PI 54% (nl 5-22). Parents. 2 sibs. maternal aunt and paternal grandmother had nl % PI; mat. grandmother had increase (44%). The boy had fasting seizure with G 32mg/dl, glucagon response (26-134). inappropriate IIG (13uUlml / l9mgldl. 16/16. 27/36) and HPI (75%). He responded to DZX after 5 days (G 69-107). 80% psncreatectomy was done at age 20 months; histology was normal. Recurrence was complete 4 nos later and DZX effective. Father, young and lean. had fasting hyper1 (53uUlml) and HPI (31%) with normal G tolerance. Mother and sister had normal % PI. HPI is not diagnostic of adenoma in infants with HG, but may indicate a familial abnormality. Good response to DZX may be a contraindication to surgery despite hyper1 andlor HPI. Respective values dropped t o 74t6 and 54f5 mgldl on day 1 o f the neonatal period. then increased i n both groups; but the IUGR r a t s remained r e l a t i v e l y hypoglycemic through day 4 (pc.01). The weight o f the IUGR r a t s was lower through the t h i r d postnatal day, reaching control l e v e l s on days 4 and 5, G6P a c t i v i t i e s increased s i m i l a r l y i n both groups during the neonatal period. The s i m i l a r FOP a c t i v i t i e s a t b i r t h (1.54f.10 and 1.47t.20 uM/min/g l i v e r ) i n control and IUGR r a t s increased i n both groups ddring the newborn period. However, a c t i v i t i e s remained s i g n i f i c a n t l y lower i n the IUGR r a t s through day 4 (3,09+0..2 vs, 4.53+0,6 vM/ minlg l i v e r i n control r a t s , p<.Dl).
Thus, low body weight. blood glucose, and hepatic FDP levels n o m l i z e d by day 5 i n newborn IUGR rats. These results suggest t h a t hypoglycemia i n the newborn IUGR r a t i s due t o a combination o f impaired glycogen stores and inadequate g l uconeogenic enzyme a c t i v i t y .
